New Hair Growth Serum vs. Minoxidil for Hair Loss
Treatments studied
Part of Skin clinical trials.
This study compares a new peptide-based hair serum with minoxidil (a common hair-regrowth treatment) in people with androgenetic alopecia, a type of hair loss caused by genetics and hormones. The trial lasts 24 weeks and measures how well each treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Diagnosed with androgenetic alopecia (genetic hair loss) at a moderate stage or worse
- Able to keep the same hairstyle and hair color for 6 months
- Willing to stop hair-loss treatments and supplements for at least 3–6 months before starting
- Can attend all study visits over 24 weeks
- No major uncontrolled health conditions (liver, kidney, thyroid, heart, diabetes, anemia)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral pill form of minoxidil, a common hair growth treatment, for men with male pattern baldness. It aims to see if the pill is safe and effective in helping hair regrow.
This trial tests a low-dose oral form of minoxidil (a hair growth medicine) for people with pattern hair loss. It aims to see if this treatment helps regrow hair in a convenient way.
This study tests a new investigational drug, OLX72021, given as injections into the scalp, to see if it can help regrow hair in men with male pattern baldness. It will also check how safe the drug is and how well it works.
This trial tests whether a lotion containing a beneficial bacteria (Lactobacillus reuteri) can help with male or female pattern hair loss. The treatment is applied directly to the scalp.
This study tests a new scalp solution (KX-826) for men with androgenetic alopecia, commonly known as male pattern baldness. It aims to see if the solution can help regrow hair and is safe to use. Participants will apply the solution to their scalp and have their hair growth monitored over time.
This trial tests a new gel made from a natural sugar molecule against a standard hair loss treatment (minoxidil). It aims to see which works better for people with mild to moderate hereditary hair loss.
Hear when a new Androgenetic Alopecia (AGA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.